VISN-wide BPA for point of care whole blood glucose testing equipment and supplies
Ended Awarded Last action
- Contract number
- 36C25625N0012
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 16
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $40,386
Award facts
- Contract value 100% obligated
- $40,386.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$20,813 | |
| Other Administrative Action | $0 | |
| Original award | $61,200 |
About this award
Roche Diagnostics Corporation received a $40,386.48 firm fixed-price Blanket Purchase Agreement (BPA) call order from Veterans Integrated Service Network 16 (VISN 16) on October 1, 2024, for point-of-care whole blood glucose testing equipment and supplies. The contract will be performed in Castleton, Indiana, with an ultimate completion date of September 30, 2025. This award is a child contract under Roche's parent General Services Administration Schedule contract for In Vitro Diagnostics, Reagents, and Test (FSS-65-VII), and carries no set-aside designation, reflecting open competition in the federal marketplace.
Roche Diagnostics Corporation is a foreign-owned, for-profit manufacturer headquartered in Indianapolis, Indiana, and serves as a primary supplier of advanced diagnostic capabilities across the Department of Veterans Affairs, Defense Health Agency, and other federal healthcare entities. The company maintains an extensive portfolio of active Indefinite Delivery Contracts and BPAs across multiple VISNs and defense agencies with values ranging from $606,000 to $6.75 million, providing diagnostic equipment, reagents, consumables, and associated testing services through fiscal year 2030. This contract award continues Roche's sustained provision of point-of-care testing solutions to support the Veterans Health Administration's clinical diagnostic requirements.
Quick answers
Who was awarded contract 36C25625N0012?
36C25625N0012 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 16 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C25625N0012 worth?
The government has obligated $40,386 on 36C25625N0012.
Is contract 36C25625N0012 an order under another contract?
Yes. 36C25625N0012 is a BPA call under V797P5279B-36C25621A0023, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25625N0012 competed?
The extent of competition for 36C25625N0012 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award